CGT Holding

CGT Holding is a biotechnology company focused on the development and commercialization of advanced cell and gene therapies. The company operates as a strategic holding entity that integrates research, development, and manufacturing capabilities to accelerate the delivery of curative treatments for cancer and rare diseases. Their portfolio includes innovative CAR-T cell therapies and stem cell-based treatments targeting high-unmet-need indications in oncology and immunology. By leveraging a vertically integrated model, CGT Holding aims to optimize the complex supply chain and manufacturing processes inherent in the cell and gene therapy sector.